Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
This study will compare the efficacy, safety and tolerability of intravenous ertapenem versus
another intravenous antibiotic in the treatment of moderate to severe diabetic foot
infections.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ertapenem Penicillanic Acid Piperacillin Piperacillin, Tazobactam Drug Combination Tazobactam